Antibodies that interfere with IL-6 function Tocilizumab is a monoclonal antibody directed against the IL-6 receptor that has established benefit in RA both with regards to clinical efficacy and ...
Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...
The anti-IL-23 monoclonal antibody, called picankibart, was shown to clear or nearly clear all lesions after 16 weeks among 48.2% of the 82 participating Chinese patients that were classified as ...
Scientists from the University of Sharjah think monoclonal antibodies hold the potential to be a far better treatment for ...
Details of the poster presentation are as follows: Poster Title: A phase 1/2 dose escalation and cohort expansion study of AU-007, a human monoclonal antibody (mAb) that binds to IL-2 and inhibits ...
Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.
They put this new approach to the test finding an antibody pair for the Simple Plex Ella platform immunoassay for the cytokine IL-10. Assays for biomarkers like IL-10 must be able to precisely ...
Clazakizumab, a monoclonal antibody that targets the inflammatory cytokine interleukin-6 (IL-6), stabilized kidney transplant ...
In addition, the data also demonstrates potent inhibition of IL-1 signaling in these ADCs-treated cell culture systems when ...
Clazakizumab, a monoclonal antibody that targets the inflammatory cytokine interleukin-6 (IL-6), stabilized kidney transplant recipients' kidney function in a Phase II trial. Investigators now ...